EU scientific panel to undertake risk assessment of medical devices containing nanomaterials
This article was originally published in Clinica
Executive Summary
The European Commission has requested SCENIHR, its Scientific Committee on Emerging and Newly-Identified Health Risks, to carry out a risk assessment of medical devices containing nanomaterials. The committee has until March 2013 to report back on the matter.